Showing results (81-90 of 130) with videos related to
Sort By:
Pageof 13
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 9, 2022
Sexual and reproductive health experiences and care of adult women with cystic fibrosisTraci M Kazmerski, Olivia M Stransky, Daniel R Lavage, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 20, 2021
Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosisJ Stuart Elborn, Michael W Konstan, Jennifer L Taylor-Cousar, et al.The Lancet. Respiratory Medicine|August 2, 2025
Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trialsNicole Mayer-Hamblett, Natanya R Kerper, John P Clancy, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 15, 2024
Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosisShijing Jia, Yizhuo Wang, Melissa H Ross, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 14, 2026
Psychometric validity of the 22-item sinonasal outcome test in cystic fibrosisChristine M Liu, Jakob L Fischer, Jonathan B Overdevest, et al.International Forum of Allergy & Rhinology|December 29, 2022
Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence-based review with recommendationsAmarbir S Gill, Jeremiah A Alt, Kara Y Detwiller, et al.Journal of Patient Experience|February 7, 2022
Engaging Stakeholders in the Development of a Reproductive Goals Decision AID for Women with Cystic FibrosisOlivia M Stransky, Molly Pam, Sigrid L Ladores, et al.JCI Insight|November 10, 2025
Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapyEszter K Vladar, Austin E Gillen, Sangya Yadav, et al.Plos One|March 2, 2013
Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survivalKenneth C Malcolm, E Michelle Nichols, Silvia M Caceres, et al.American Journal of Respiratory and Critical Care Medicine|March 15, 2023
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del AlleleJennifer L Goralski, Jordana E Hoppe, Marcus A Mall, et al.Pageof 13